|
100
|
400
|
3udmA |
Crystal structure of bace with compound 8 |
|
15
|
99
|
3upjA |
Human immunodeficiency virus type 2 protease mutant with lys 57 replaced by leu (k57l) complex with u096333 [4-hydroxy-3-[1-(phenyl)propyl]-7-methoxycoumarin] |
|
102
|
400
|
3udhA |
Crystal structure of bace with compound 1 |
|
96
|
389
|
3uflA |
Discovery of pyrrolidine-based b-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency |
|
90
|
329
|
3urjA |
Type iv native endothiapepsin |
|
102
|
400
|
3udrA |
Crystal structure of bace with compound 14 |
|
16
|
99
|
3ucbA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 in complex with darunavir |
|
16
|
99
|
3uhlA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 in complex with p2-nc substrate analog |
|
100
|
400
|
3udnA |
Crystal structure of bace with compound 9 |
|
82
|
326
|
3utlA |
Human pepsin 3b |
|
93
|
391
|
3uqwA |
Crystal structure of bace1 with its inhibitor |
|
100
|
400
|
3udjA |
Crystal structure of bace with compound 5 |
|
102
|
400
|
3udyA |
Crystal structure of bace with compound 11 |
|
84
|
329
|
3urlA |
Endothiapepsin-db6 complex. |
|
19
|
99
|
3ufnA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 in complex with saquinavir |
|
100
|
400
|
3udqA |
Crystal structure of bace with compound 13 |
|
102
|
400
|
3udpA |
Crystal structure of bace with compound 12 |
|
17
|
99
|
3u7sA |
Hiv pr drug resistant patient's variant in complex with darunavir |
|
16
|
99
|
3u71A |
Crystal structure analysis of south african wild type hiv-1 subtype c protease |
|
18
|
99
|
3ttpA |
Structure of multiresistant hiv-1 protease in complex with darunavir |
|
96
|
391
|
3tpjA |
Apo structure of bace1 |
|
17
|
99
|
3tofA |
Hiv-1 protease - epoxydic inhibitor complex (ph 6 - orthorombic crystal form p212121) |
|
19
|
103
|
3tkgA |
Crystal structure of hiv model protease precursor/saquinavir complex |
|
89
|
392
|
3tplA |
Apo structure of bace1 |
|
91
|
387
|
3tprA |
Crystal structure of bace1 complexed with an inhibitor |
|
18
|
99
|
3togA |
Hiv-1 protease - epoxydic inhibitor complex (ph 9 - monoclinic crystal form p21) |
|
16
|
99
|
3tkwA |
Crystal structure of hiv protease model precursor/darunavir complex |
|
17
|
99
|
3tlhA |
Structural studies of hiv and fiv proteases complexed withan efficient inhibitor of fiv pr |
|
18
|
99
|
3tl9A |
Crystal structure of hiv protease model precursor/saquinavir complex |
|
86
|
339
|
3tneA |
The crystal structure of protease sapp1p from candida parapsilosis in complex with the hiv protease inhibitor ritonavir |
|
102
|
390
|
3tppA |
Crystal structure of bace1 complexed with an inhibitor |
|
18
|
99
|
3tohA |
Hiv-1 protease - epoxydic inhibitor complex (ph 9 - orthorombic crystal form p212121) |
|
17
|
99
|
3th9A |
Crystal structure of hiv-1 protease mutant q7k v32i l63i with a cyclic sulfonamide inhibitor |
|
88
|
330
|
3t7xA |
Endothiapepsin in complex with an inhibitor based on the gewald reaction |
|
18
|
99
|
3t3cA |
Structure of hiv pr resistant patient derived mutant (comprising 22 mutations) in complex with drv |
|
84
|
330
|
3t7pA |
Endothiapepsin in complex with a hydrazide derivative |
|
89
|
330
|
3t6iA |
Endothiapepsin in complex with an azepin derivative |
|
86
|
330
|
3t7qA |
Endothiapepsin in complex with an inhibitor based on the gewald reaction |
|
14
|
99
|
3t11A |
Dimeric inhibitor of hiv-1 protease. |
|
19
|
99
|
3st5A |
Crystal structure of wild-type hiv-1 protease with c3-substituted hexahydrocyclopentafuranyl urethane as p2-ligand, grl-0489a |
|
23
|
95
|
3sqfA |
Crystal structure of monomeric m-pmv retroviral protease |
|
19
|
99
|
3spkA |
Tipranavir in complex with a human immunodeficiency virus type 1 protease variant |
|
97
|
387
|
3skfA |
Crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with (2s)-2-((3s)-3-(acetylamino)-3-(butan-2-yl)-2-oxopyrrolidin-1-yl)-n-((2s,3r)-3-hydroxy-4-((3-methoxybenzyl)amino)-1-phenylbutan-2-yl)-4-phenylbutanamide |
|
23
|
114
|
3slzA |
The crystal structure of xmrv protease complexed with tl-3 |
|
20
|
113
|
3sm1A |
The crystal structure of xmrv protease complexed with pepstatin a |
|
15
|
99
|
3so9A |
Darunavir in complex with a human immunodeficiency virus type 1 protease variant |
|
86
|
386
|
3skgA |
Crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with (2s)-2-((3r)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-n-((1s,2r)-1-(3,5-difluorobenzyl)-2-hydroxy-2-(1,2,3,4-tetrahydro-3-isoquinolinyl)ethyl)-4-phenylbutanamide |
|
21
|
114
|
3sm2A |
The crystal structure of xmrv protease complexed with amprenavir |
|
88
|
340
|
3sfcA |
Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors |
|
32
|
127
|
3s8iA |
The retroviral-like protease (rvp) domain of human ddi1 |
